Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature

被引:15
作者
Di Carlo, Isidoro [1 ]
Mannino, Maurizio [1 ]
Toro, Adriana [1 ]
Ardiri, Annalisa [2 ]
Galia, Antonio [3 ]
Cappello, Giovanni [1 ]
Bertino, Gaetano [2 ]
机构
[1] Univ Catania, Cannizzaro Hosp, Dept Surg Sci Organ Transplantat & Adv Technol, Catania, Italy
[2] Univ Catania, S Marta Hosp, Dept Internal Med & Syst Dis, Hepatol Unit, I-95126 Catania, Italy
[3] Cannizzaro Hosp, Dept Pathol, I-95124 Catania, Italy
关键词
Alpha-fetoprotein; Hepatectomy; HCC without cirrhosis; HCC; HEPATIC RESECTION; EARLY RECURRENCE; RISK-FACTORS; DIAGNOSIS; PROGNOSIS; FEATURES; MARKERS;
D O I
10.1186/1477-7819-10-79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Alpha-fetoprotein (AFP) is an oncofetal protein produced by hepatocellular carcinoma (HCC). AFP level can also be elevated in other neoplastic or non-neoplastic conditions. An elevated AFP level has high diagnostic significance for HCC; at a level of >200 ng/mL, the probability of HCC is >90%. The aim of the present paper is to report a patient who underwent curative resection of HCC, who had a persistently elevated AFP level postoperatively but did not develop recurrence during a 2-year follow-up period. A review of the literature is also presented. Case report: An 82-year-old male was referred following a computed tomography scan showing a 160 mm diameter mass in the left lobe of the liver. This huge mass was diagnosed as HCC, arising in the absence of cirrhosis or viral hepatitis. After tumor removal, the patient's high AFP level persisted for 2 years. Conclusion: As steatosis was the only pathological change in the remnant liver, this may have caused the persistently elevated AFP level in this patient.
引用
收藏
页数:6
相关论文
共 40 条
[1]   Hepatocellular cancer in the non-cirrhotic liver [J].
Alkofer, B. ;
Lepennec, V. ;
Chiche, L. .
JOURNAL OF VISCERAL SURGERY, 2011, 148 (01) :3-10
[2]  
[Anonymous], 1979, GASTROENTEROLOGY, V76, P1089
[3]   The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis [J].
Arrieta, Oscar ;
Cacho, Bernardo ;
Morales-Espinosa, Daniela ;
Ruelas-Villavicencio, Ana ;
Flores-Estrada, Diana ;
Hernandez-Pedro, Norma .
BMC CANCER, 2007, 7 (1)
[4]   Serum α-fetoprotein levels in liver steatosis [J].
Babali, Ayseguel ;
Cakal, Erman ;
Purnak, Tugrul ;
Biyikoglu, Ibrahim ;
Cakal, Basak ;
Yuksel, Osman ;
Koklu, Seyfettin .
HEPATOLOGY INTERNATIONAL, 2009, 3 (04) :551-555
[5]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[6]   Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? [J].
Chagas, A. L. ;
Kikuchi, L. O. O. ;
Oliveira, C. P. M. S. ;
Vezozzo, D. C. P. ;
Mello, E. S. ;
Oliveira, A. C. ;
Cella, L. C. ;
Herman, P. ;
Bachella, T. ;
Caldwell, S. H. ;
Alves, V. A. F. ;
Carrilho, F. J. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (10) :958-962
[7]  
Chan SL, 2009, FUTURE ONCOL, V5, P889, DOI [10.2217/fon.09.64, 10.2217/FON.09.64]
[8]   Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver [J].
Chang, CH ;
Chau, GY ;
Lui, WY ;
Tsay, SH ;
King, KL ;
Wu, CW .
ARCHIVES OF SURGERY, 2004, 139 (03) :320-325
[9]  
Chau GY, 1997, J SURG ONCOL, V66, P122, DOI 10.1002/(SICI)1096-9098(199710)66:2<122::AID-JSO9>3.0.CO
[10]  
2-F